Acamprosate for the treatment of alcohol use disorder may be safer than baclofen in patients with cirrhosis

被引：0
|
作者：
Tyson, Luke D. [1 ,2 ]
Cheng, Alexandra [2 ]
Kelleher, Charles [2 ]
Strathie, Kirstin [2 ]
Lovendoski, James [2 ]
Habtemariam, Zebib [2 ]
Lewis, Heather [2 ]
机构：
[1] Imperial Coll London, Dept Metab Digest & Reprod, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Hepatol, London, England
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-607
引用
收藏
页码：S314 / S314
页数：1
相关论文
共 50 条
  • [41] A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder
    de Beaurepaire, Renaud
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [42] FPIN's Clinical Inquiries Baclofen for Alcohol Use Disorder
    Kondrad, Elfin
    Bonner, Abria
    Sandhu, Stephanie
    Seitz, Kathryn
    Weldon, Stephanie
    AMERICAN FAMILY PHYSICIAN, 2024, 109 (05) : 463 - 464
  • [43] Hierarchical Bayesian pharmacometrics analysis of Baclofen for alcohol use disorder
    Baldy, Nina
    Simon, Nicolas
    Jirsa, Viktor K.
    Hashemi, Meysam
    MACHINE LEARNING-SCIENCE AND TECHNOLOGY, 2023, 4 (03):
  • [44] Baclofen in the treatment of alcohol use disorders: descriptive and retrospective study of 184 patients
    Tournebize, Juliana
    Fristot, Lisa
    Bisch, Michael
    Georget, Sebastien
    Gibaja, Valerie
    Dobre, Daniela
    THERAPIE, 2021, 76 (02): : 177 - 177
  • [45] ACAMPROSATE-AN ANTI-CRAVING DRUG FOR ALCOHOL USE DISORDER (AUD) PHARMACOTHERAPY: PLASMA METABOLOMICS SIGNATURES ARE ASSOCIATED WITH ALCOHOL CRAVING INTENSITY AND ACAMPROSATE TREATMENT RESPONSE.
    Ho, M.
    Zhang, C.
    Zhang, L.
    Moon, I.
    Geske, J.
    Choi, D.
    Biernacka, J.
    Oesterle, T.
    Frye, M.
    Seppala, M.
    Li, H.
    Karpyak, V.
    Weinshilboum, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S18 - S18
  • [46] A prospective cohort study examining the effectiveness of baclofen in the maintenance of abstinence in alcohol use disorder patients attending a joint liver and alcohol treatment clinic
    Owens, Lynn
    Thompson, Andrew
    Rose, Abi
    Gilmore, Ian
    Pirmohamed, Munir
    Richardson, Paul
    ALCOHOL, 2017, 62 : 11 - 15
  • [47] STATIN USE IS ASSOCIATED WITH REDUCED INCIDENT CIRRHOSIS IN PATIENTS WITH ALCOHOL USE DISORDER AND HYPERLIPIDEMIA
    Przybyszewski, Eric
    Vannier, Augustin
    Diaz, Paige McLean
    Mahle, Rachael
    Tsai, Stephanie
    Shay, Jessica
    Patel, Suraj J.
    Chung, Raymond T.
    Schaefer, Esperance
    Goodman, Russell P.
    Luther, Jay
    HEPATOLOGY, 2022, 76 : S993 - S993
  • [48] Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial
    Rombouts, Susan A.
    Baillie, Andrew
    Haber, Paul S.
    Morley, Kirsten C.
    ALCOHOL AND ALCOHOLISM, 2019, 54 (03): : 272 - 278
  • [49] ALCOHOL USE DISORDER TREATMENT IS ASSOCIATED WITH REDUCED DECOMPENSATION EVENTS IN VETERANS WITH CIRRHOSIS
    Rogal, Shari S.
    Youk, Ada
    Zhang, Hongwei
    Gellad, Walid
    Fine, Michael J.
    Good, Chester
    Chartier, Maggie
    DiMartini, Andrea F.
    Morgan, Timothy R.
    Bataller, Ramon
    Kraemer, Kevin
    HEPATOLOGY, 2019, 70 : 817A - 817A
  • [50] Association of acamprosate versus gabapentinoids with hospitalization and total mortality in alcohol use disorder
    Shah, Raj
    Zelneronok, Kirsten A.
    Henriquez, Richard
    Mansi, Ishak A.
    JOURNAL OF HOSPITAL MEDICINE, 2025,
12345